Trump's 100% Pharma Tariffs Target Patented Imports—IP Chaos Ahead
President Trump's bold EO slaps 100% tariffs on imported patented pharmaceuticals. Drugmakers face a stark choice: move to America or pay up.
⚡ Key Takeaways
Worth sharing?
Get the best Legal Tech stories of the week in your inbox — no noise, no spam.
Originally reported by IPWatchdog